Cargando…

In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography

BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrupatla, Durga M. S. H., Jansen, Gerrit, Vos, Ricardo, Verlaan, Mariska, Chen, Qingshou, Low, Philip S., Windhorst, Albert D., Lammertsma, Adriaan A., van der Laken, Conny J., Molthoff, Carla F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452381/
https://www.ncbi.nlm.nih.gov/pubmed/28569209
http://dx.doi.org/10.1186/s13075-017-1325-x
_version_ 1783240406400499712
author Chandrupatla, Durga M. S. H.
Jansen, Gerrit
Vos, Ricardo
Verlaan, Mariska
Chen, Qingshou
Low, Philip S.
Windhorst, Albert D.
Lammertsma, Adriaan A.
van der Laken, Conny J.
Molthoff, Carla F. M.
author_facet Chandrupatla, Durga M. S. H.
Jansen, Gerrit
Vos, Ricardo
Verlaan, Mariska
Chen, Qingshou
Low, Philip S.
Windhorst, Albert D.
Lammertsma, Adriaan A.
van der Laken, Conny J.
Molthoff, Carla F. M.
author_sort Chandrupatla, Durga M. S. H.
collection PubMed
description BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-based positron emission tomography (PET) tracer [(18)F]fluoro-PEG-folate. The purpose of this study was to examine whether this folate tracer can also be used to monitor therapeutic efficacy of MTX in arthritic rats. METHODS: Arthritic rats received either no treatment or MTX therapy (1 mg/kg, either 2× or 4×). Healthy rats did not receive any arthritic induction or therapy. [(18)F]fluoro-PEG-folate PET-CT scans (60 min) were performed before and after MTX therapy. Following PET, the ex-vivo tissue distribution of radioactivity was determined in excised knees and multiple tissues. Synovial macrophage infiltration in knee sections was quantified by immunohistochemistry using ED1 and ED2 antibodies. RESULTS: PET scans clearly visualized increased uptake of [(18)F]fluoro-PEG-folate in arthritic knees compared with contralateral knees. Significantly lower standard uptake values (1.5-fold, p < 0.01) were observed in arthritic knees of both MTX-treated groups after therapy, approximating the levels seen in healthy rats. Consistently, ex-vivo tissue distribution demonstrated a 2–4-fold lower tracer uptake in the arthritic knee of 2× and 4× MTX-treated rats, respectively, compared with control rats. These results were corroborated with significantly reduced (2–4-fold, p < 0.01) ED1-positive and ED2-positive synovial macrophages in arthritic knees of the MTX-treated rats compared with those of the control rats. CONCLUSION: This study in arthritic rats underscores the potential and usefulness of [(18)F]fluoro-PEG-folate PET as a therapeutic monitoring tool of MTX therapy and potentially other anti-folate treatment of arthritis.
format Online
Article
Text
id pubmed-5452381
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54523812017-06-01 In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography Chandrupatla, Durga M. S. H. Jansen, Gerrit Vos, Ricardo Verlaan, Mariska Chen, Qingshou Low, Philip S. Windhorst, Albert D. Lammertsma, Adriaan A. van der Laken, Conny J. Molthoff, Carla F. M. Arthritis Res Ther Research Article BACKGROUND: Folate receptor β (FRβ) is involved in facilitating cellular uptake of folates and anti-folates (such as methotrexate (MTX)). In rheumatoid arthritis, FRβ is expressed on synovial macrophages and recently has been explored as a biomarker for imaging in arthritic rats using the folate-based positron emission tomography (PET) tracer [(18)F]fluoro-PEG-folate. The purpose of this study was to examine whether this folate tracer can also be used to monitor therapeutic efficacy of MTX in arthritic rats. METHODS: Arthritic rats received either no treatment or MTX therapy (1 mg/kg, either 2× or 4×). Healthy rats did not receive any arthritic induction or therapy. [(18)F]fluoro-PEG-folate PET-CT scans (60 min) were performed before and after MTX therapy. Following PET, the ex-vivo tissue distribution of radioactivity was determined in excised knees and multiple tissues. Synovial macrophage infiltration in knee sections was quantified by immunohistochemistry using ED1 and ED2 antibodies. RESULTS: PET scans clearly visualized increased uptake of [(18)F]fluoro-PEG-folate in arthritic knees compared with contralateral knees. Significantly lower standard uptake values (1.5-fold, p < 0.01) were observed in arthritic knees of both MTX-treated groups after therapy, approximating the levels seen in healthy rats. Consistently, ex-vivo tissue distribution demonstrated a 2–4-fold lower tracer uptake in the arthritic knee of 2× and 4× MTX-treated rats, respectively, compared with control rats. These results were corroborated with significantly reduced (2–4-fold, p < 0.01) ED1-positive and ED2-positive synovial macrophages in arthritic knees of the MTX-treated rats compared with those of the control rats. CONCLUSION: This study in arthritic rats underscores the potential and usefulness of [(18)F]fluoro-PEG-folate PET as a therapeutic monitoring tool of MTX therapy and potentially other anti-folate treatment of arthritis. BioMed Central 2017-05-31 2017 /pmc/articles/PMC5452381/ /pubmed/28569209 http://dx.doi.org/10.1186/s13075-017-1325-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chandrupatla, Durga M. S. H.
Jansen, Gerrit
Vos, Ricardo
Verlaan, Mariska
Chen, Qingshou
Low, Philip S.
Windhorst, Albert D.
Lammertsma, Adriaan A.
van der Laken, Conny J.
Molthoff, Carla F. M.
In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title_full In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title_fullStr In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title_full_unstemmed In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title_short In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography
title_sort in-vivo monitoring of anti-folate therapy in arthritic rats using [(18)f]fluoro-peg-folate and positron emission tomography
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452381/
https://www.ncbi.nlm.nih.gov/pubmed/28569209
http://dx.doi.org/10.1186/s13075-017-1325-x
work_keys_str_mv AT chandrupatladurgamsh invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT jansengerrit invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT vosricardo invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT verlaanmariska invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT chenqingshou invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT lowphilips invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT windhorstalbertd invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT lammertsmaadriaana invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT vanderlakenconnyj invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography
AT molthoffcarlafm invivomonitoringofantifolatetherapyinarthriticratsusing18ffluoropegfolateandpositronemissiontomography